1-2 of 2
Philip Ancliff
Close
Sort by
Journal Articles

Maintenance therapy for early loss of B-cell aplasia after anti-CD19 CAR T-cell therapy

Maria Gabelli, Macarena Oporto-Espuelas, Saskia Burridge, Jan Chu, Susan Farish, Emma Hedges, Kirsty Ware, Lindsey Williams, Lindsey Young, Rajesh Alajangi, Philip Ancliff, Jack Bartram, Denise Bonney, Lenka Chenchara, Robert Chiesa, Chiara Cugno, Katharine Hodby, Katarzyna A. Jalowiec, Arina Lazareva, Giovanna Lucchini, Oana C. Mirci-Danicar, Khushnuma Mullanfiroze, Vesna Pavasovic, Anupama Rao, Kanchan Rao, Lynne Riley, Sujith Samarasinghe, Geoff Shenton, Juliana Silva, Ajay Vora, Rachael Hough, Persis J. Amrolia, Sara Ghorashian
Journal: Blood Advances
Blood Adv (2024) 8 (8): 1959–1963.
https://doi.org/10.1182/bloodadvances.2023011168
Published: 2024
Includes: Supplemental data
Journal Articles

CD1a is rarely expressed in pediatric or adult relapsed/refractory T-ALL: implications for immunotherapy

Sarah Leong, Sarah Inglott, Foteini Papaleonidopoulou, Karen Orfinada, Philip Ancliff, Jack Bartram, Ben Carpenter, Adele K. Fielding, Sara Ghorashian, Victoria Grandage, Rajeev Gupta, Rachael Hough, Asim Khwaja, Vesna Pavasovic, Anupama Rao, Sujith Samarasinghe, Ajay Vora, Marc R. Mansour, David O’Connor
Journal: Blood Advances
Blood Adv (2020) 4 (19): 4665–4668.
https://doi.org/10.1182/bloodadvances.2020002502
Published: 2020
Includes: Supplemental data